Glaukos secured a new FDA clearance for its miniaturized stent system designed for glaucoma to help drain the inner eye of built-up fluids and normalize intraocular pressure. The company had received ...
NEW YORK (CBS.MW) -- Upcoming results, good or bad, from European trials of Boston Scientific's new drug-coated stent are likely to set the tone for the company's shares, according to Barron's. Stents ...
Ivantis Inc. in Irvine closed on a $25 million Series C funding round for development and eventual marketing of a stent intended for use in glaucoma surgery. New investor RA Capital Management LLC in ...
On a hilltop overlooking Camp Pendleton, some of the world’s smallest medical devices are being made. About 225 employees of Glaukos Corp. (NYSE: GKOS) peer into microscopes, constructing daily ...
Optometrist Dr. David Kordish often talks to patients about glaucoma and cataracts in doing general eye care. Now, he can see his patients with clearer vision and freedom from glaucoma medication ...
The London Ophthalmology Centre (LondonOC) has developed a new, non-invasive technique for the application of Xen stent into the eye to treat acute glaucoma. The micro device and new technique was ...
ZURICH, Aug 29 (Reuters) - Novartis eye care unit Alcon is voluntarily withdrawing its CyPass Micro-Stent after follow-up clinical data showed patients using the product experienced statistically ...
LOS ANGELES, March 14, 2017 /PRNewswire-USNewswire/ -- As a national leader in innovative ophthalmology treatments that prevent blindness the University of Southern California (USC) Roski Eye ...
Blake Williamson, MD, performed the first Xen Gel Stent procedure form Allergan Surgical in Louisiana at the Williamson Eye Center in Baton Rouge, according to a Weekly Citizen report. Here are five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback